Polycomb group (PcG) proteins assemble to form large multiprotein complexes involved in gene silencing. Evidence suggests that PcG complexes are heterogeneous with respect to both protein composition and speci®c function. MPc3 is a recently described mouse Polycomb (Pc) protein that shares structural homology with at least two other Pc proteins, M33 and MPc2. All three Pc proteins bind another PcG protein, RING1, through a conserved carboxy-terminal C-box motif. Here, data are presented demonstrating that MPc3 also interacts with AF9, a transcriptional activator implicated in the development of acute leukemias. The carboxy-terminus of AF9 is fused to the MLL protein in leukemias characterized by t(9;11)(p22;q23) chromosomal translocations. Importantly, it is the carboxy-terminus of AF9 to which MPc3 binds. The AF9 binding site of MPc3 maps to a central, non-conserved, region of the polypeptide sequence. In contrast to MPc3, data indicate that the Pc protein M33 does not interact with AF9. This ®nding suggests a potentially unique role for MPc3 in linking a PcG silencing complex to a transcriptional activator protein. Oncogene (2001) 20, 3798 ± 3805. 
Introduction
The Polycomb group (PcG) encompasses a structurally diverse family of proteins that participate in gene silencing, a phenomenon characterized by the stable transcriptional repression of target genes. Null mutations of PcG genes in¯ies and mice result in anomalous antero-posterior development due to Hox gene derepression. PcG proteins are thought to repress their targets by modifying chromatin structure (reviewed in Pirrotta, 1997 Pirrotta, , 1998 Schumacher and Magnuson, 1997; van Lohuizen, 1999) . As a class, the PcG proteins are uni®ed by mutual physical interactions giving rise to large multimeric protein complexes that assemble at speci®c sites on chromosomes termed Polycomb response elements (PREs) (Franke et al., 1992; Shao et al., 1999) . Models have been proposed in which the PcG complex facilitates thè spreading' of heterochromatin over distances of several kilobases. Alternative models in which PcG complexes interact with and stabilize other DNAbound gene regulatory proteins through`looping' of large segments of DNA have also been described (Pirrotta, 1998) . Importantly, a direct physical interaction between a human PcG protein EED and histone deacetylase HDAC2 has recently been reported (van der Vlag and Otte, 1999) . Recruitment of histone deacetylase activity by PcG proteins may favor the development of compact heterochromatin and a transcriptionally silent domain.
PcG genes were ®rst described in Drosophila and genetic analysis has revealed as many as 40 unique loci in that species (JuÈ rgens, 1985) . Among the PcG genes that have been cloned and characterized in Drosophila and mammals, the predicted protein products are remarkable for their structural diversity. However, characterization of both¯y and mammalian PcG proteins indicates that the individual PcG proteins contain one or more domains that mediate binding to other PcG proteins. Thus multiple protein ± protein contacts appear to be made within a PcG complex serving to stabilize the structure through mutual interactions (Alkema et al., 1997a; Gunster et al., 1997; Peterson et al., 1997; Schoorlemmer et al., 1997; Hashimoto et al., 1998; Hemenway et al., 1998) . These ®ndings are consistent with the long-standing observation that single PcG gene mutations produce a relatively mild phenotype while multiple mutations act synergistically to produce severe developmental anomalies.
To date, at least two PcG complexes can be distinguished on the basis of subunit composition, subnuclear localization and proposed function. It has been suggested that the complex containing EED and EZH/Enx plays a role in the initiation of PcG-mediated gene repression in very early embryogenesis. Another complex contains Pc, Ph, Bmi-1, and RING1 proteins and may be more important in maintaining the stable repressed state , van Lohuizen, 1999 Sewalt et al., 1998; Shao et al., 1999) . Further structural and functional categorization of PcG complexes has yet to be reported, however the situation is likely to be more complicated, particularly in mammals in which orthologous PcG proteins have been described with overlapping but distinct functional properties (Sewalt et al., 1999) .
Not surprisingly, searches for other proteins that physically interact with PcG proteins have revealed other PcG proteins. However, among the numerous PcG-interacting proteins, several non-PcG proteins have now been described that may provide a better understanding of the functional properties of PcG complexes. The association of EED with histone deacetylases is noted above. The Drosophila PcG protein CRM co-localizes with Proliferating Cell Nuclear Antigen (Yamamoto et al., 1997) . Additionally, GAGA factor can be detected in some PcG complexes and, notably, a subset of PREs in Drosophila contains GAGA binding sites Horard et al., 2000) . The interaction of PcG complexes with other proteins has begun to provide clues as to the mechanisms of PcG function.
We have identi®ed a mouse homolog of Drosophila Pc protein, designated MPc3 (Hemenway et al., 2000) . At least two other mouse Pc proteins, M33 and MPc2, have also been described (Pearce et al., 1992; Alkema et al., 1997a) . We ®nd that MPc3 physically associates with a nuclear protein designated AF9. AF9 was initially cloned from human leukemia specimens characterized by a t(9;11)(p22;q23) translocation (Nakamura et al., 1993; Iida et al., 1993) . AF9 is thus one of many genes that are fused to the mixed lineage leukemia (MLL) gene as a result of balanced translocations involving the MLL locus at 11q23. Translocations at 11q23 give rise to in-frame fusion genes that likely participate in leukemogenesis. The role of AF9 under normal conditions has not been fully evaluated, however, studies of the AF9 homolog ENL show that it may function as a transcriptional activator (Rubnitz et al., 1994) . The ®nding of a physical association between AF9 and MPc3 suggests that complexes containing PcG complexes are quite heterogeneous and may link proteins involved transcriptional repression with transcriptional activators.
Results

MPc3 interacts with AF9 in the yeast two-hybrid system
MPc3 is the third mouse Pc protein whose complete sequence has been described (Hemenway et al., 2000) . A human homolog, HPc3, has subsequently been identi®ed as well (BaÂ rdos et al., 2000) . As a de®ning feature of Pc proteins, MPc3 contains a highly conserved amino-terminal chromodomain and a carboxy-terminal C-box. However, apart from these characteristic domains, MPc3 shares little sequence similarity with its homologs, M33 and MPc2 (Pearce et al., 1992; Alkema et al., 1997a) . We performed a twohybrid selection employing the complete MPc3 molecule as`bait' to identify proteins that may associate with PcG complexes containing MPc3. et al., 2000) . In fact, based on restriction analysis and DNA sequencing, RING1A and dinG/RING1B represented 1/16 and 10/16 speci®c interacting proteins, respectively. One of the 16 library isolates, the subject of this report, contained a 0.4 kb cDNA insert whose sequence revealed the 3' portion of the mouse AF9 gene. This AF9 two-hybrid plasmid contains an in-frame fusion between the GAL4 transactivation domain and the 3' end of AF9 encoding the carboxy-terminal 94 amino acids. The corresponding portion of the human AF9 gene sequence is found within MLL-AF9 fusion genes resulting from t(9;11)(p22;q23) translocations (Iida et al., 1993; Nakamura et al., 1993) . The encoded amino acid sequence is highly conserved between AF9 and ENL and is predicted to form two putative ahelices. In the case of ENL, it has been demonstrated that the carboxy-terminal portion is required for neoplastic transformation of primitive hematopoietic progenitor cells expressing an MLL-ENL fusion gene (Slany et al., 1998) .
MPc3 and AF9 co-precipitate in vitro and in vivo
In order to further support the ®nding that MPc3 physically interacts with AF9, the proteins were tested for their ability to bind in vitro. An anity matrix was prepared from recombinant GST-MPc3 202 ± 362 protein expressed in E. coli. This GST fusion protein contains the carboxy terminus of MPc3 from amino acid 202 ± 362 and was immobilized on glutathione-agarose resin.
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S-radiolabeled AF9 prepared by coupled in vitro transcription/translation of the full-length human AF9 cDNA is retained by the GST-MPc3 202 ± 362 anity matrix but not by GST (Figure 1 ). Based on a comparison of the input radiolabeled AF9 and that recovered by GST pulldown, approximately 1.5% of the radiolabeled product is retained (data not shown). These results indicate that MPc3 and AF9 either bind each other directly or bind in conjunction with a factor present in the reticulocyte lysates.
The physical association of MPc3 and AF9 was then examined in vivo by immunoprecipitation. NIH3T3 cells were transfected with plasmids expressing FLAGtagged AF9 and HA-tagged MPc3. Cell lysates were mixed with anti-FLAG antibodies. Antibody-protein complexes were then recovered, separated by SDS ± PAGE and immunoblotted with anti-HA antibody. HA-tagged MPc3 is precipitated by anti-FLAG antibodies only when co-expressed with FLAG-tagged AF9 ( Figure 2 ). This result is consistent with yeast two-hybrid data and GST pulldown experiments that Mpc3 and AF9 form a stable protein complex.
MPc3 and AF9 co-localize in the nuclei of NIH3T3 cells
The subcellular localization of MPc3 and AF9 was examined in un®xed mammalian cells by expressing GFP-and RFP-tagged proteins in NIH3T3 cells. When expressed alone (data not shown) or in conjunction with AF9,¯uorescent protein-tagged MPc3 is found distributed throughout the nucleus in small punctate structures ( Figure 3 ). This pattern is strikingly similar to other PcG proteins that have been analysed by immuno¯uorescence microscopy (Alkema et al., 1997a, b; Gunster et al., 1997; Schoorlemmer et al., 1997; Hashimoto et al., 1998) . Like MPc3, tagged AF9 is localized to the nucleus and also assumes a punctate pattern of distribution. Importantly, when tagged AF9 and MPc3 are co-expressed, both proteins are detected in subnuclear structures that coincide precisely. Thus, in addition to assays of direct protein ± protein interaction that suggest AF9 and MPc3 form a stable physical complex, both MPc3 and AF9 appear as mutual components of discrete subnuclear structures. These data demonstrate that MPc3 and AF9 are capable of interacting under physiologic conditions and contribute to the assembly of multiprotein complexes that are similar in appearance to previously described PcG complexes.
The mouse AF9 gene is nearly identical to human AF9 and is widely expressed in adult tissues
We attempted to isolate the complete 5' end of mouse AF9 by RACE from 11 day embryo cDNA but were S-Met-labeled AF9 prepared by coupled transcription/translation reaction was incubated with the anity matrix and washed repeatedly. Bound protein was recovered by boiling, separated by SDS-polyacrylamide gel electrophoresis, and analysed by autoradiography Figure 2 Co-precipitation of MPc3 and AF9 in vivo. MPc3 and AF9 were tagged at the amino-terminus with HA and FLAG epitopes, respectively and were expressed in NIH3T3 cells. Total cell lysates were immunoprecipitated with anti-FLAG antibody. Precipitated proteins were resolved by SDS ± 12% PAGE, transferred to nitrocellulose, and probed with anti-HA antibody. HA-MPc3, indicated by ("), migrates as a *40 kDa protein. It is detected in anti-FLAG immune complexes when co-expressed with FLAG-tagged AF9. The 40 kDa protein is not detected in anti-FLAG immune complexes from cells that co-express HAMPc3 with the empty parent FLAG expression vector (FLAGCx) or in cells co-expressing the empty HA expression vector (HA-Cx) with FLAG-AF9. The upper band at *50 kDa is nonspeci®c able only to amplify a 0.8 kb molecule containing gene sequence encoding the mid-portion of the AF9 protein.
A forward primer derived from the human AF9 sequence encoding the ®rst nine amino acids of the protein was therefore used in conjunction with a mouse AF9 sequence reverse primer to amplify the 5' region of the mouse AF9 open reading frame. Excluding the ®rst nine amino acids, the mouse and human protein sequences are 97.7% identical. The GenBank accession number is AF333960.
AF9 gene expression was examined by PCR ampli®cation of ®rst strand cDNA derived from dierent mouse tissues. Under these assay conditions, AF9 expression is observed in all mouse tissues analysed. Particularly high levels of expression are noted in the spleen, and expression during embryogenesis appears highest in early embryos (Figure 4) . These results are in general agreement with analyses of AF9 transcripts in humans and rats by Northern blot (Iida et al., 1993; Morgan et al., 2000) .
MPc3 binds AF9 within a region that is not conserved in other Polycomb proteins
The Polycomb (Pc) proteins are conserved from Drosophila to mammals and are characterized by a conserved amino-terminus chromodomain as well as a carboxy-terminus`C-box'. Multiple protein interactions involving Polycomb proteins have been described to date that demonstrate the importance of the C-box. The C-box is necessary and sucient for Pc proteins to bind other PcG proteins RING1A and RING1B (Schoorlemmer et al., 1997; Satijn and Otte, 1999; Hemenway et al., 2000) . We employed yeast twohybrid assays to map the interaction domain of MPc3 with AF9. Fragments of MPc3 were expressed as Gal4 DNA binding domain chimeras and were tested for their ability to interact with the carboxy-terminus of AF9 ( Figure 5 ). The results of these experiments indicate that the amino-terminal chromodomain of MPc3 does not contribute signi®cantly to AF9 binding. Somewhat surprisingly, we ®nd that the conserved Cbox of MPc3 is neither sucient nor necessary for AF9 binding. Speci®cally, yeast two-hybrid mapping studies indicate that aa 202 ± 333, a portion of MPc3 that lacks the C-box, encompasses the AF9 binding interface. In contrast, a two-hybrid protein consisting of aa 314 ± 362 and containing the C-box of MPc3 cannot bind AF9 although it produces a robust interaction with the PcG protein RING1B under similar assay conditions. In sum, neither the amino-terminal chromodomain nor the carboxy-terminal C-box of MPc3 is responsible for AF9 binding. Rather, a region of MPc3 contained within the central portion of the amino acid sequence confers the ability to bind AF9. Inspection of this region of MPc3 reveals no sequence similarities to other known Pc proteins.
AF9 interaction is not a property of all Pc proteins
Residues 202 ± 333 of MPc3 are located within the central portion of the protein and lack sequence similarity to other human and mouse Pc proteins that have been described to date (Hemenway et al., 2000) . We therefore wished to determine whether other Pc proteins interact with AF9. In a yeast two-hybrid assay of the full-length M33 protein, M33 and AF9 fail to interact. Appropriate function of the chimeric M33 protein under the assay conditions is indicated by its ability to interact with the PcG protein RING1B. Collectively, these ®ndings suggest that the ability of MPc3 to associate with AF9 is not a general property of all Pc proteins but may be unique to MPc3. Figure 4 Expression pattern of AF9 in the mouse. First strand cDNA from a panel of mouse tissues was obtained commercially. cDNA was ampli®ed by PCR as described in Materials and methods using an AF9-speci®c primer set. The PCR product was resolved by agarose gel electrophoresis. G3PDH was ampli®ed as a positive control reaction Figure 5 Map of the AF9 interaction domain of MPc3. Fulllength or fragments of the MPc3 protein were expressed as Gal4 DNA-binding domain chimeras and were tested for their ability to interact in a yeast two-hybrid assay with (1) the carboxyterminal 94 aa of mouse AF9 or (2) mouse RING1B. AF9 and RING1B were expressed as Gal4 transactivation domain chimeras. The size of each MPc3 fragment is indicated by amino acid positions. Shaded boxes indicate the location of the aminoterminal chromodomain and the carboxy-terminal C-box. A positive two-hybrid signal is measured by adenine prototrophy of three or more independent transformed yeast colonies.`0' indicates no growth on adenine-de®cient synthetic medium. +++' indicates growth on adenine-de®cient medium that is equivalent to growth on medium containing adenine and absence of red pigment accumulation Previous studies reveal that M33, like MPc3 and AF9 is distributed throughout the nucleus as subnuclear`speckles' (Schoorlemmer et al., 1997; Hashimoto et al., 1998). Although we failed to detect a direct interaction between M33 and AF9 in a yeast twohybrid assay, we wished to investigate the possibility that M33 might co-localize with MPc3 and AF9 as components of a heteromeric multiprotein complex. Fluorescent protein-tagged M33 was expressed in NIH3T3 cells either with or without tagged AF9. Both M33 and AF9 assume a punctate subnuclear pattern as was observed in similar experiments expressing MPc3 and AF9. However, in contrast to the experiments employing MPc3 and AF9, the distribution of M33 and AF9 throughout the nucleus is largely nonoverlapping ( Figure 6 ). These ®ndings suggest that while MPc3, M33 and AF9 comprise elements of speci®c subnuclear structures, these structures are distinct. One class of structures contains both MPc3 and AF9 but excludes M33. Another class contains the Pc protein M33 but neither MPc3 nor AF9. These ®ndings are consistent with a model in which the dierent Pc proteins contribute to unique multimeric structures based on their speci®c ability to bind other proteins.
MPc3 has distinct protein binding sites and facilitates multiprotein complex formation
Data suggest that PcG proteins assemble as large multiprotein complexes stabilized by mutually interacting binding partners (Hashimoto et al., 1998; Hemenway et al., 1998; Satijn and Otte, 1999) . The C-box at the extreme carboxy-terminus of MPc3 is responsible for interactions with the proteins RING1A and RING1B (Hemenway et al., 2000) , a characteristic that is shared with other Pc proteins. In this study, we show that MPc3 is also capable of binding AF9 through a centrally located portion of its sequence. These ®ndings raise the possibility that MPc3 is capable of simultaneously binding both RING1A/B and AF9 thereby stabilizing a heterotrimeric protein structure. To test this possibility, RING1B and the carboxy-terminus of AF9 were tested for their ability to interact in a yeast two-hybrid assay. When expressed as a Gal4 binding domain chimera, we ®nd that AF9 does not interact with a RING1B-Gal4 activation domain chimera. However, if full-length MPc3 is coexpressed in yeast in conjunction with the AF9 and RING1B hybrid proteins, robust reporter gene activity is detected. Similar results are obtained if the AF9 and RING1B proteins are fused to the opposite Gal4 domains. This ®nding demonstrates that binding of AF9 to the mid-portion of MPc3 allows the additional binding of RING1A/B to the MPc3 C-box (Figure 7) .
Discussion
In this study we identify the putative oncoprotein AF9 as a binding partner of MPc3 and ®nd that the carboxy-terminal 94 amino acids of AF9 are sucient for binding to MPc3. The AF9 locus at chromosome band 9p22 is a common site of gene rearrangement involving MLL. Moreover, the chimeric genes resulting from t(9;11)(p22;q23) translocations that have been molecularly cloned are predicted to encode a relatively small carboxy-terminal portion of the AF9 protein fused to a considerably larger portion of MLL at the amino-terminus (Iida et al., 1993; Nakamura et al., 1993) . Thus the portion of AF9 required for MPc3 binding is contained within MLL-AF9 fusion proteins.
The role of AF9 in biologic systems has not been fully established, however, evidence suggests that AF9 may function as a transcription factor. Reporter gene assays employing the AF9 homolog, ENL, indicate that a Gal4-ENL fusion protein activates transcription. Furthermore, the carboxy-terminal 90 amino acids of ENL, a region that is highly homologous to AF9, contains the transactivation domain. Using a luciferase reporter gene and a Gal4-AF9 fusion protein, we also ®nd that the carboxy-terminus of AF9 can function to activate transcription in NIH3T3 cells (data not shown). Although they do not de®ne a role for the normal AF9 protein, several investigations have examined the function of MLL-AF9 and MLL-ENL fusion proteins. Of great interest is the ®nding that experimental replacement of a normal MLL allele by MLL-AF9 induces acute leukemia in mice. Under these conditions, the carboxy-terminus AF9 is required for leukemogenesis (Corral et al., 1996) . Similarly, the intact carboxy-terminus of MLL is required for transformation in hematopoietic progenitor cells transfected with MLL-ENL fusion proteins (Slany et al., 1998) .
What is the relationship between MPc3 and AF9? We ®nd that AF9 binds and co-localizes with MPc3, therefore AF9 may serve as an additional component of MPc3-containing PcG complexes. In arti®cial reporter gene assays, PcG proteins are consistently shown to repress gene expression (Bunker and Kingston, 1994; Schoorlemmer et al., 1997) , and targeted disruption of PcG genes in mice leads to derepression of homeotic genes (van der Lugt et al., 1994; Takihara et al., 1997; Bel et al., 1998) . In contrasts, AF9 and its homolog ENL activate gene expression in similar assays (see above). Hence, these basic properties of PcG proteins and AF9 are at odds. It will be important to establish a functional relationship between these proteins.
The ability to bind AF9 is not shared by all Pc proteins. The AF9 binding site is located within a region of MPc3 that is not conserved among the mammalian Pc homologs described to date. Dierential binding of other proteins by Pc members is not unprecedented. The human Pc protein HPc2 interacts with the transcriptional repressor C-terminal binding protein (CtBP) while M33 does not. Mapping studies indicate that a 6 amino acid motif contained within HPc2 mediates CtBP binding and this motif is absent from M33 (Sewalt et al., 1999) . Therefore, in addition to containing dierent PcG members, PcG complexes likely associate with other non-PcG proteins through the unique protein binding characteristics of the speci®c PcG constituents. Heterogeneity among PcG complexes may confer an enhanced ability to regulate the expression of diverse genes, but it remains to be established how this is accomplished.
One general feature of PcG proteins that is re¯ected by MPc3 is the ability to form multimeric complexes through non-overlapping protein binding sites. Several PcG proteins have been described that have the capacity to simultaneously bind multiple other PcG proteins (Hashimoto et al., 1998; Hemenway et al., 1998; Satijn and Otte, 1999) . Data presented here indicate that MPc3 can simultaneously bind both RING1B and AF9 to form a trimeric complex. In turn, RING1 may interact with other PcG proteins even when bound to MPc3. Under these conditions, we propose that the physical association of MPc3 with AF9 serves to incorporate AF9 within a PcG complex.
Last, it may be particularly noteworthy that MPc3 binds the carboxy-terminus of AF9. It is this portion of the AF9 molecule that is fused to MLL as a consequence of balanced translocations at (9;11)(p22;q23).
Although not yet tested, it may be possible for MPc3 to associate with chimeric MLL-AF9 oncoproteins. Such an interaction might recruit a PcG protein to a chimeric MLL protein. This, in turn, may lead to the establishment of a PcG complex at a locus normally occupied by MLL. PcG complex assembly at a MLL DNA binding site might lead to dysregulated gene expression contributing to leukemogenesis.
Materials and methods
Yeast two-hybrid system
Yeast cells and expression plasmids were manipulated according to standard protocols. A two-hybrid selection was performed using the complete MPc3 open reading frame cloned into pGBT9 as a`bait' plasmid and a mouse 11 day embryo cDNA library cloned in vector pGAD10 (Clontech) as`prey'. Yeast strain PJ69-4A was transformed with LiOAc and incubated on synthetic medium lacking adenine, leucine, and tryptophan. Ade + colonies were selected and tested for histidine prototrophy on synthetic medium containing 1 mM 3-aminotriazole and lacking histidine, leucine and trytophan. Library DNA was isolated from Ade + His + colonies and yeast cells were transformed with bait and prey plasmids to con®rm the phenotype. The speci®city of the two-hybrid interaction was tested using a lamin bait plasmid.
Protein interaction assays were also performed using yeast strain PJ69-4A. Yeast two-hybrid expression vectors were produced by cloning restriction endonuclease fragments or PCR products into either pGBT9 (GAL4 DNA binding domain) or pGAD424 (GAL4 transactivating domain). In some experiments, a third heterologous protein was expressed from the yeast expression vector pBEVY-U containing the relevant mammalian cDNA sequence. PCR-generated fragments were subjected to DNA sequence analysis. A detailed description of plasmids used for mapping studies of interacting protein domains will be provided upon request. Following transformation of strain PJ69-4A with these plasmids, a minimum of three Leu + Trp + (or Leu + Trp + Ura + as indicated) colonies was selected and tested for adenine prototrophy. Cells transformed with the bait plasmid and the empty two-hybrid expression vector pGAD424 were tested in parallel as a negative control.
PCR amplification of cDNA
A portion of the 5' end of the mouse cDNA sequence was derived by RACE. DNA was ampli®ed from an adaptorligated mouse 11 day embryo cDNA pool (Clontech) as follows. An adaptor-speci®c primer (AP1) from the commercial kit was used with the AF9-speci®c primer: 5'-GCTGCA-GAATGTGTCGTTCCCTCAGTGTCA-3' in a primary reaction with the following parameters: 948630 s; 94865 s, 70864 min for ®ve cycles; 94865 s, 68864 min for 30 cycles; 68865 min. One ml of the primary PCR product was then used as a template for a secondary nested reaction with adaptor-speci®c primer (AP2) from the commercial kit, AF9-speci®c primer: 5'-CCCTCAGTGTCATTAACCTTCTGTG-GAGCT-3' and the following parameters: 948630 s; 94865 s, 64864 min for 32 cycles; 64865 min. The resulting 0.8 kb PCR amplicon was cloned into pGEM-T-Easy (Promega).
An additional 5' segment of the mouse AF9 sequence was ampli®ed from mouse lung single strand cDNA by PCR using a mouse AF9-speci®c reverse primer: 5'-AC-CTTGTTGCCTGGTCTGGGATGGTGTG-3' and a forward primer based on the human AF9 sequence (NM_004529): 5'-ATGGCTAGCTCGTGTTCCGTGCAG-GTG. Reaction parameters were: 948630 s; 94865 s, 67863 min for 35 cycles; 67865 min. The 1.1 kb PCR amplicon was cloned into pGEM-T-Easy (Promega).
Tissue-speci®c expression of AF9 was analysed by PCR ampli®cation of a mouse multiple tissue ®rst strand cDNA panel (Clontech) with the mouse AF9-speci®c reverse primer: 5'-ACCTTGTTGCCTGGTCTGGGATGGTGTG-3' and mouse AF9-speci®c forward primer: 5'-CTTACTCACCGT-CACCAGTGGGCAGCA-3'. Reaction parameters were: 948630 s; 94865 s, 67861 min for 32 cycles; 67865 min. G3PDH was ampli®ed as a control with the reverse primer: 5'-CATGTAGGCCATGAGGTCCACCAC-3' and the forward primer: 5'-TGAAGGTCGGTGTGAACGGATTTG-GC-3'. Reaction parameters were: 948630 s; 94865 s, 68862 min for 28 cycles; 68865 min.
GST protein binding assay
A GST-MPc3 fusion protein was produced by cloning a fragment of the MPc3 gene encoding the C-terminal 160 aa into pGEX-5X-1 (Amersham-Pharmacia). Recombinant protein was isolated from E. coli strain BL21 following induction with 0.1 mM IPTG at 308C for 4 h.
Radiolabeled AF9 protein was synthesized by coupled in vitro transcription/translation employing T7 polymerase and rabbit reticulocyte lysates (Promega). Total reaction volume was 50 ml and contained 60 mCi [ Binding assays were performed by mixing 100 ml bacterial lysate to 50 ml GSH-agarose (Amersham-Pharmacia) at 48C for 60 min. The anity matrix was washed ®ve times with cold binding buer (PBS pH=7.4, 1 mM EDTA, 1 mM DTT, 1% Triton X-100, 0.5% NP-40, 1 mg/ ml BSA). After washing, the matrix was resuspended in 200 ml binding buer. Ten ml of the radiolabeled protein mixture was added and the matrix was incubated at 48C for an additional 60 min followed by six washes with cold binding buer. Three hundred ml of protein loading buer were added to the matrix, and the mixture was boiled for 5 min. Twenty ml of the supernatant was separated by SDS ± 12% polyacrylamide gel electrophoresis. The gel was ®xed in Amplify solution (Amersham-Pharmacia), dried and exposed to ®lm.
Co-precipitation assay
The full-length human cDNA sequence of AF9 was inserted into the p3xFLAG-CMV-10 expression vector (Sigma) to produce an amino-terminus FLAG-tagged AF9 molecule. Similarly, the full-length mouse cDNA sequence of MPc3 was inserted into pHA-CMV (Clontech) to generate aminoterminus HA-tagged MPc3. NIH3T3 cells were co-transfected with the AF9 and MPc3 expression vectors as well as with the`empty' parent vectors as controls. Cells were transfected in 25 cm 2¯a sks using Lipofectamine Plus reagent (Life Technologies). Twenty-four hours following transfection, cells were harvested in 1 ml PBS pH=7.5 with protease inhibitor cocktail (Sigma) and sonicated. Four hundred ml of the cell lysates were mixed with 8 mg mouse monoclonal anti-FLAG M2 antibody (Sigma) and incubated at 48C for 60 min. Immune complexes were recovered during a 3 h incubation at 48C with 50 ml Protein-A agarose slurry (Roche). The Protein-A agarose was then washed twice with 1 ml cold TBS buer containing 140 mM NaCl, 20 mM TrisHCl pH=7.6, 1 mM EDTA and 0.1% NP-40 followed by two additional washes with the same buer but lacking EDTA. The Protein-A agarose-bound proteins were separated by SDS ± 12% PAGE and transferred to nitrocellulose. The nitrocellulose membrane was blocked in TBS buer with 2% non-fat dry milk and 0.1% Tween. It was then incubated overnight in fresh TBS/milk/Tween containing a 1 : 2000 dilution of the anti-HA mouse monoclonal antibody 11.1 (gift of Erik Flemington). The membrane was probed with peroxidase-linked goat anti-mouse IgG antibodies (Roche) and the signal was detected by ECL (Amersham/Pharmacia).
Fluorescent protein microscopy
The complete open reading frames of human AF9, mouse MPc3, and mouse M33 were ampli®ed by PCR using Pfu polymerase (Stratagene). The PCR amplicons were cloned into pEGFPC1 (green¯uorescent protein) and pDsRedC1 (red¯uorescent protein) (Clontech). The DNA sequence of cloned PCR fragments was con®rmed.
NIH3T3 cells were grown in medium consisting of DMEM supplemented with L-glutamine, 1% non-essential amino acids, 1% sodium pyruvate and 10% calf serum. Cells were transfected in 100 mm dishes using 0.5 mg of each plasmid DNA with Lipofectamine Plus reagent (Life Technologies) according to the manufacturer's protocol. Twenty-four to forty-eight hours after transfection, cells were washed in PBS and observed directly with a Leica DMIRB inverted uorescence microscope. Chroma ®lter sets #41001 and #31000 were used for visualization of green and red uorescent proteins, respectively. Images were initially captured at 4006magni®cation and sized for ®gures using Adobe Photoshop software. 
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